In the first published study of its kind, researchers from the Catholic University/Policlinico Gemelli in Rome, Italy, and NewYork-Presbyterian/Weill Cornell Medical Center found that bariatric surgery dramatically outperforms standard medical treatment of severe type 2 diabetes.
Researchers at Weill Cornell Medical College have developed a computer program that has tracked the manner in which different forms of dementia spread within a human brain. They say their mathematic model can be used to predict where and approximately when an individual patient's brain will suffer from the spread, neuron to neuron, of "prion-like" toxic proteins -- a process they say underlies all forms of dementia.
NewYork-Presbyterian Hospital is the recipient of a five-year grant, totaling up to $900,000, from the New York State Department of Health to reduce the asthma burden in New York City.
A supporter and champion of biomedical research, Dr. Herbert Pardes, executive vice chairman of the NewYork-Presbyterian Hospital Board of Trustees, has established and endowed a prestigious award that will be presented annually to a physician-scientist whose research exemplifies the very best in scientific advancement and innovation.
Nationwide ambulance use by patients suffering from a stroke has not changed since the mid-1990s, even though effective stroke treatments are now available. In a study published in this week's Journal of the American Medical Association (JAMA), researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center found that the number of stroke victims transported via ambulance has remained relatively static over the years, highlighting the need for more education about stroke symptoms and the importance of early intervention.
Jeffrey Lieberman, MD, Psychiatrist-in-Chief at NewYork-Presbyterian Hospital/Columbia University Medical Center and Chair of the Department of Psychiatry at Columbia University College of Physicians and Surgeons has been elected by the membership of the American Psychiatric Association to be the next president-elect. His term as president-elect and then president will begin May 2012 and extend through April 2014.
By engineering cells to express a modified RNA called "Spinach," researchers have imaged small-molecule metabolites in living cells and observed how their levels change over time. Metabolites are the products of individual cell metabolism. The ability to measure their rate of production could be used to recognize a cell gone metabolically awry, as in cancer, or identify the drug that can restore the cell's metabolites to normal.
Katie Couric, NewYork-Presbyterian and its Jay Monahan Center for Gastrointestinal Health, the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (NCCRA), and ABC today announced the "Make That Call" campaign to promote colon cancer screening for National Colon Cancer Awareness Month. During the month of March, the campaign will urge New Yorkers age 50 and older, as well as those at increased risk for the disease, to call their doctors to make an appointment to be screened for colon cancer, the second-leading cause of cancer death in the U.S. According to the New York City Department of Health and Mental Hygiene, colonoscopy is the preferred colon cancer screening test in New York City.
The number two cancer killer in the U.S. is often preventable and highly curable.
Oncologists have known that in order for cancer cells to spread, they must transform themselves so they can detach from a tumor and spread to a distant organ. Now, scientists at Weill Cornell Medical College have revealed critical steps in what happens next -- how these cells reverse the process, morphing back into classical cancer that can now grow into a new tumor.
By employing complex machine learning techniques to decipher repeated advanced brain scans, researchers at New York-Presbyterian/Weill Cornell were able to provide evidence that a patient with a severe brain injury could, in her way, communicate accurately.
A nationwide, federally funded study has found that testing a developing fetus’ DNA through chromosomal microarray (CMA) provides more information about potential disorders than does the standard method of prenatal testing, which is to visually examine the chromosomes (karyotyping). The results of the 4,000-plus-participant clinical study are being presented at the 32nd annual meeting of the Society for Maternal-Fetal Medicine in Dallas on Feb. 9, 2012. The study was recently published in the American Journal of Obstetrics & Gynecology.
Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.
Physicians at three transplant centers have found in a pilot study that a majority of children who receive liver tissue from a parent can eventually stop using immunosuppression (anti-rejection) medications safely. These drugs, which tamp down natural immune function, have been linked to a bevy of complications, including cancer, diabetes, hypertension and kidney failure.
NewYork-Presbyterian Hospital/Columbia University Medical Center is the first hospital in the New York metro area to offer breast cancer survivors an at-home method for tissue expansion in preparation for breast reconstruction surgery. Patients use a remote control to gradually create a space within their chest wall for a breast implant.
Despite advances in the diagnosis and treatment of unruptured brain aneurysms, outcomes have remained stagnant over the last 10 years. This can be explained by the dramatic proliferation of minimally invasive endoscopic coiling procedures at lower-volume community hospitals, where outcomes are inferior.
Weill Cornell Medical College has announced the establishment of the Office of Faculty Development dedicated to assisting its physicians, researchers and educators in achieving academic success at each stage of their careers, with targeted activities that focus on the needs of junior, mid-career and senior faculty.
The experience of daily positive affect -- a mild, happy feeling -- and self-affirmation helps some patients with chronic diseases, including coronary artery disease, high blood pressure and asthma, make better decisions about their health. These findings are detailed in three studies of 756 patients published online in the Jan. 23 edition of the Archives of Internal Medicine -- the first large, randomized controlled trials to show that people can use positive affect and self-affirmation to help them make and sustain behavior change.
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women.
Patients with coronary artery disease -- blockages of the vessels that feed the heart -- can be treated in a number of ways. With their doctor, they decide on the best course of action: surgery, stent placement or medication. Sometimes, a combination of these is the best approach.
The risk for heart-related death is increasing in young adults ages 35 to 54, and the numbers are even more alarming for younger women. It is the number-one cause of death for both men and women in the United States, yet every year since 1984 more women have died of cardiovascular health problems than men, according to the American Heart Association.
While we may be accustomed to battling frigid temperatures and the inevitable snow storms that arrive every winter, many of us are unaware of the dangers these pose to our hearts.
Love is in the air, but Valentine's Day shouldn't be the only time to express love for your partner; rather, it should serve as a reminder to devote time and energy to your relationship every day.
Dr. Joseph F. Artusio Jr., the founding chairman of the Department of Anesthesiology and anesthesiologist-in-chief at what is today known as Weill Cornell Medical College and NewYork-Presbyterian Hospital/Weill Cornell Medical Center, died on Dec. 21 at the age of 94.
FDA-Initiated International Consortium of Orthopaedic Registries (ICOR) will work to develop an infrastructure for enhanced safety monitoring.
NewYork-Presbyterian Hospital's Westchester Division has been formally named by Planetree Inc. as a "Planetree Designated Patient-Centered Hospital" in recognition of the Hospital's achievement and innovation in the delivery of patient-centered care.
Patients need less blood after surgery than is widely thought. A new study comparing two plans for giving blood transfusions following surgery showed no ill effects from postponing transfusion until patients develop signs of anemia or their hemoglobin concentration falls below 8 g/dL.
Surgeons at NewYork-Presbyterian Hospital/Columbia University Medical Center performed the first Total Artificial Heart implant in the New York City area to replace a patient's dying heart.
The activity and excitement of the holidays tend to make people less careful when they should be more cautious. In the United States, there are an estimated 47,000 fires every holiday season that claim more than 500 lives a year.
The U.S. Environmental Protection Agency (EPA) has awarded its ENERGY STAR® certification to NewYork-Presbyterian Hospital/Weill Cornell Medical Center's flagship building at 525 East 68th Street -- the only hospital facility certified in New York City in 2011.
A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.
A 59-year-old woman from upstate New York and a 60-year-old woman from the New York metro area were the first patients in New York state and among the first in the United States to receive transplanted lungs that were assessed and reconditioned in the operating room -- a technique that has the potential to dramatically increase the availability of lungs for transplant. The experimental procedure was performed by Dr. Frank D'Ovidio at NewYork-Presbyterian Hospital/Columbia University Medical Center.
One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments geared toward the targeting of specific cancer-causing mechanisms is hampered by lack of knowledge of the molecular pathways that drive cancers in individual patients.
More than 270,000 Americans get hip replacement surgeries every year. With various options for implants, including metal-on-polyethylene, metal-on-metal and ceramic-on-ceramic, there have been questions about which kind works best. A new FDA-funded data analysis, the first of its kind, has found no clear advantage of one implant type over another in terms of effectiveness but presented evidence of a potential for harm associated with metal-on-metal implants.
Dr. Andrew B. Lassman has joined the Neurological Institute at NewYork-Presbyterian Hospital/Columbia University Medical Center as chief of neuro-oncology, a new program focusing on caring for patients with brain tumors and metastases as well as research into new treatments. Dr. Lassman has also been named to the faculty of Columbia University College of Physicians and Surgeons.
Scientists at Weill Cornell Medical College used genetic methods to successfully repair cleft lips in mice embryos specially engineered for the study of cleft lip and cleft palate. The research breakthrough may show the way to prevent or treat the conditions in humans.
Older adults receiving home health care may be taking a drug that is unsafe or ineffective for someone their age. In fact, nearly 40 percent of seniors receiving medical care from a home health agency are taking at least one prescription medication that is considered potentially inappropriate to seniors, a new study in the Journal of General Internal Medicine has revealed.
NewYork-Presbyterian Hospital/Columbia University Medical Center has officially opened the Center for Acute Respiratory Failure, which offers, among other services, expertise in using lung bypass technology to help adult patients whose lungs are rapidly shutting down.
An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers.
Dana Buchman, fashion designer and founder of the Promise Project, and Eugene Lang, entrepreneur and founder of the Lang Youth Medical Program and I Have A Dream Foundation, will each be honored with an Award for Distinguished Service by the Columbia Presbyterian Health Sciences Advisory Council. The award ceremony will take place on Thursday, Nov. 10, at the Vivian and Seymour Milstein Family Heart Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, 173 Ft. Washington Ave., N.Y.C. (9:30 a.m., 12 p.m. award ceremony).
To diagnose autism spectrum disorders, clinicians typically administer a variety of tests or scales and use information from observations and parent interviews to classify individuals into subcategories listed in standard psychiatric diagnostic manuals. This process of forming "best-estimate clinical diagnoses" has long been considered the gold standard, but a new study demonstrates that these diagnoses are widely variable across centers, suggesting that this may not be the best method for making diagnoses.
In the presence of U.S. Congresswoman Carolyn B. Maloney, Weill Cornell Medical College today dedicated the Belfer Research Building, a state-of-the-art facility that will more than double the Medical College's existing research space and position Weill Cornell at the vanguard of new medical research and discoveries. A ceremony was held to recognize the generosity of the building's many donors, including a $100 million gift from Renée and Robert Belfer, for whom the building is named.
Sharon Greenberger is joining NewYork-Presbyterian Hospital’s management team as senior vice president for facilities development and engineering, effective today. She was most recently chief operating officer of the New York City Department of Education.
NewYork-Presbyterian Hospital/Columbia University Medical Center today became the first in the United States to implant the SAPIEN transcatheter aortic heart valve as an FDA-approved standard of care. This major advance in patient care follows the FDA's decision on Nov. 2 to approve SAPIEN as a preferred treatment for patients too sick to undergo traditional aortic valve surgery.
NewYork-Presbyterian is ranked 23rd on the 2011 InformationWeek 500 — the magazine’s annual list of the top technology innovators in the United States — and is the second highest ranking hospital in the nation.
Researchers at Weill Cornell Medical College say they have taken an important step forward in their quest to "turn on" lung regeneration — an advance that could effectively treat millions of people suffering from respiratory disorders.
Dr. Frank A. Chervenak, the Given Foundation Professor and chairman of the Department of Obstetrics and Gynecology at Weill Cornell Medical College and obstetrician and gynecologist-in-chief and director of maternal-fetal medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, has been elected to the Institute of Medicine (IOM) of the National Academies. IOM membership is considered one of the highest honors in the fields of health and medicine.
In what is so far the largest investigation of its kind, researchers uncovered a wide range of new insights about common diseases and how they are affected by differences between two persons' genes. The results from this study could lead to highly targeted, individualized therapies.
The American Association for Cancer Research (AACR) has presented the 2011 AACR–Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research to Dr. Andrew J. Dannenberg, director of the Weill Cornell Cancer Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and the Henry R. Erle, M.D.–Roberts Family Professor of Medicine at Weill Cornell Medical College.
Funded through Bloomingdale's annual Pink Campaign, The Breast Cancer Research Foundation® (BCRF) is awarding a grant to Dr. Andrew J. Dannenberg of Weill Cornell Medical College on Oct. 26 to fund research into the link between obesity, inflammation and breast cancer. Dr. Dannenberg has been a BCRF grantee since 2004.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right